• English
    • français
  • Help
  •  | 
  • Contact
  •  | 
  • About
  •  | 
  • Login
  • HAL portal
  •  | 
  • Pages Pro
  • EN
  •  / 
  • FR
View Item 
  •   LillOA Home
  • Liste des unités
  • Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
  • View Item
  •   LillOA Home
  • Liste des unités
  • Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Nutritional and Gastrointestinal Management ...
  • BibTeX
  • CSV
  • Excel
  • RIS

Document type :
Article dans une revue scientifique
DOI :
10.1542/peds.2018-0333G
PMID :
30275249
Permalink :
http://hdl.handle.net/20.500.12210/4493
Title :
Nutritional and Gastrointestinal Management of the Patient With Duchenne Muscular Dystrophy.
Author(s) :
Brumbaugh, David [Auteur]
Watne, Laura [Auteur]
gottrand, frederic [Auteur] refId
Lille Inflammation Research International Center - U 995 [LIRIC]
Gulyas, Ann [Auteur]
Kaul, Ajay [Auteur]
Larson, Jacqueline [Auteur]
Tomezsko, Jean [Auteur]
Journal title :
Pediatrics
Abbreviated title :
Pediatrics
Volume number :
142
Pages :
S53-S61
Publication date :
2018-10-01
ISSN :
1098-4275
1098-4275
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
Advances in treatment and multidisciplinary management have resulted in improved survival of individuals with Duchenne muscular dystrophy (DMD). Updated DMD treatment recommendations as found in the 2018 DMD Care ...
Show more >
Advances in treatment and multidisciplinary management have resulted in improved survival of individuals with Duchenne muscular dystrophy (DMD). Updated DMD treatment recommendations as found in the 2018 DMD Care Considerations are aimed to assist multidisciplinary care teams in providing standardized care to their patients, including attention to nutritional and gastrointestinal health. Challenges remain for care teams in accurately estimating height and nutritional status for individuals with DMD. It can be difficult for patients to maintain a healthy weight. Risk factors for obesity include glucocorticoid therapy and loss of ambulation. In contrast, in the later stages of the disease, swallowing dysfunction can lead to poor nutrition and consideration for gastrostomy tube placement. Constipation is highly prevalent, underrecognized, and undertreated in DMD. With this article, we address the assessment and management of gastrointestinal and nutritional issues, as well as clinical controversies.Show less >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
Inserm
Université de Lille
CHU Lille
Collections :
  • Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
Research team(s) :
Nutritional modulation of inflammation and infection
Submission date :
2019-03-01T14:07:56Z
Université de Lille

Mentions légales
Université de Lille © 2017